Product News and Recalls

Stevens Johnson Syndrome can cause lingering effects

Stevens-Johnson syndrome, which can cause the top layer of skin to shed and die, is a painful and potentially deadly condition usually caused by an allergic reaction to medication, infection or illness.

It requires hospitalization, frequently in an intensive care unit or burn unit. But according to the Stevens Johnson Syndrome Foundation, patients who suffer a bout may have to contend with the after-effects for a long time afterward – perhaps the rest of their lives.

Lingering side effects may include:

  • Permanent loss ...
continue reading...

Diabetes drug looks good in study

The blog FiercePharma reports that the diabetes drug Victoza has performed well in a clinical study – performing better than competitors Januvia and Byetta in keeping patients’ blood sugar below a target of 7 percent.

Novo Nordisk, Victoza’s manufacturer, is working to secure more of an edge in what the blog entry describes as “the fast-growing diabetes market.” But it will likely face challenges in the form of a marketing blitz ...

continue reading...

FDA, state officials take look at compounding pharmacies

During a conference that included public health officials from all 50 states, the U.S. Food and Drug Administration examined the role of the federal government in regulating “compounding pharmacies.”

A compounding pharmacy called the New England Compounding Center – where specialty drugs are prepared using ingredients from other sources – produced the steroid medication responsible for the 19-state fungal meningitis outbreak that has so far sickened 620 ...

continue reading...

Company conducting trial on new diabetes drug

Poxel SA, a France-based company spun off from the pharmaceutical division of Merck, has raised $17.1 million in venture backing to fund a clinical trial for an experimental Type 2 diabetes drug, Bloomberg reports.

According to Bloomberg, the compound imeglimin is part of a new class of oral anti-diabetics called glimins, and has shown promising results in previous trials.

A safer alternative to existing medications could be a potentially lucrative market for ...

continue reading...

Study reaches controversial conclusion about 9/11 cancer

A study has found that three types of cancer spiked among first responders at the scene of the 9/11 terrorist attacks, but there was no overall increase in cancer among people exposed to debris at Ground Zero in Manhattan.

A story in the New York Daily News notes that six months ago, the federal government agreed to add 50 types of cancer to the illnesses eligible for compensation from a $4.3 ...

continue reading...

Brain-injured man gets multi-million settlement

A report in the British newspaper Gloucestershire Echo concerns a man awarded more than 3.5 million pounds, the equivalent of $5.7 million, for brain injuries he sustained during birth.

Jacob Dewis had filed the lawsuit against Nuneaton Maternity Hospital, where he was born 20 years ago. He alleged that doctors delayed an emergency delivery, which resulted in acute oxygen starvation during his delivery.

Dewis ended up with ...

continue reading...
Page 273 of 386 «...250260270271272273274275...»